share_log

Barinthus Biotherapeutics Reports 'Encouraging' Phase 2b HBV003 Trial Results for Chronic Hepatitis B

Barinthus Biotherapeutics Reports 'Encouraging' Phase 2b HBV003 Trial Results for Chronic Hepatitis B

Barinthus生物治療公司報告了針對慢性乙型肝炎的'鼓舞人心'的20億HBV003試驗結果。
MT Newswires ·  2024/11/16 01:29

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論